| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5873512 | Journal of Stroke and Cerebrovascular Diseases | 2014 | 8 Pages |
Abstract
IV-TPA treatment can be safely and efficaciously administered to eligible Korean patients up to the extended time window of 4.5Â hours. However, efforts to expedite the treatment should not be neglected.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Tai Hwan MD, PhD, Ji Sung PhD, Sang-Soon MD, Youngchai MD, Soo Joo MD, PhD, Kyung Bok MD, PhD, Jun MD, PhD, Kyusik MD, PhD, Jong-Moo MD, PhD, Jay Chol MD, PhD, Dong-Eog MD, PhD, Yong-Jin MD, PhD, Joon-Tae MD, PhD, Dae-Hyun MD, PhD, Jae-Kwan MD, PhD,